New York 2025-2026 Regular Session

New York Senate Bill S06422

Introduced
3/13/25  

Caption

Provides that prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy maybe include the name of the dispensing practice instead of the prescriber; provides for notice to patients.

Companion Bills

NY A06927

Same As Provides that prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy maybe include the name of the dispensing practice instead of the prescriber; provides for notice to patients.

Previously Filed As

NY S09945

Permits prescription labels for medication abortion prescription drugs to include the name of the prescribing health care practice instead of the name of the prescriber at the prescriber's request.

NY S01043

Relates to the dispensing of self-administered hormonal contraceptives; authorizes a licensed physician and a certified nurse practitioner to prescribe and order a non-patient specific order to a pharmacist licensed and located in the state for the dispensing of self-administered hormonal contraceptives.

NY A01060

Relates to the dispensing of self-administered hormonal contraceptives; authorizes a licensed physician and a certified nurse practitioner to prescribe and order a non-patient specific order to a pharmacist licensed and located in the state for the dispensing of self-administered hormonal contraceptives.

NY A04494

Provides that every insurance policy which provides coverage for prescription drugs shall insure that there is continuous coverage of a single source drug that is part of a prescribed therapy until such prescribed therapy is no longer medically necessary for the enrollee of such policy; defines "single source drug".

NY S07344

Provides that every insurance policy which provides coverage for prescription drugs shall insure that there is continuous coverage of a single source drug that is part of a prescribed therapy until such prescribed therapy is no longer medically necessary for the enrollee of such policy; defines "single source drug".

NY A00582

Ensures that step therapy shall not apply to medically necessary prescription drugs in the dermatologic, hematology, ophthalmologic, rheumatic, gastrointestinal, neurology, and oncology therapeutic classes, including non-formulary drugs.

NY S02682

Ensures that step therapy shall not apply to medically necessary prescription drugs in the dermatologic, hematology, ophthalmologic, rheumatic, gastrointestinal, neurology, and oncology therapeutic classes, including non-formulary drugs.

NY S08096

Relates to the effectiveness of a chapter of the laws of 2023 relating to the dispensing of self-administered hormonal contraceptives; provides such provisions will take effect January 1, 2024.

NY A08540

Relates to the effectiveness of a chapter of the laws of 2023 relating to the dispensing of self-administered hormonal contraceptives; provides such provisions will take effect January 1, 2024.

NY S04096

Provides for random testing for anabolic steroids in athletes in public and private schools; appropriates $1,000,000 therefor.

Similar Bills

No similar bills found.